Business

Gas injection into European UGS facilities at three-year low in early August

Currently, European UGS facilities are 57.87% full compared to 70% in the previous year

Trade turnover between Armenia, Russia falls 20.9% in 1H — Armenian statistical committee

The number declined to $2.6 bln in the reporting period

China’s Robots Know Kung Fu and Can Scale Walls. Can They Woo Investors?

Unitree Robotics wants to raise about $900 million in an I.P.O. that tests market interest in humanoid robots, a technology that wows but has yet to prove its viability.

Top US Mortgage Lender Plunges Most Ever After Pausing Dividend

Shares in United Wholesale Mortgage fell by a record 49% Thursday, after the country’s biggest mortgage lender announced a net loss of $452 million and suspended its dividend for the first time.

Fox won't renegotiate NFL media rights before current deal expires, CEO Lachlan Murdoch says

Fox has decided not to renegotiate its current TV deal with the NFL until the expiration of the league's opt-out clause in 2030, said CEO Lachlan Murdoch.

How to earn a 9% dividend yield while cutting your risk in the stock market

Your own evolving goals might point the way to a different type of exchange-traded fund.

CMBS Investors Push Back Against AI as ‘Luddite Trade’ Spreads

Tech companies are borrowing far and wide to fund their artificial intelligence investments, and even in smaller markets investors are growing increasingly wary of the debt.

Datadog’s stock slides after earnings. This is what’s nagging at investors.

The cloud-monitoring company faced a high bar due to its strong stock performance this year and ended up beating expectations by less than it did in the prior quarter.

SpaceX stuck in tight range as lockup expiry adds to post-IPO woes

SpaceX shares slip as lockup expiry adds to post-IPO woes

SpaceX rebounds from post-earnings slide as investors eye lockup expiry

The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings

As Lilly widens its lead in the obesity race, Novo is still racing to win back market share and restore investor confidence in its pipeline.